NEWS
TOPICS
Cancer Vaccines
Clinical Trials
Emerging Markets
Infectious Diseases
Influenza
Manufacturing
Partnering
R&D
Regulatory
Supply Chain
ANALYSIS
FiercePharma news, curated by the crowd
by Tracy Staton

A prosperous new year for pharma? Let's check the tea leaves
by Tracy Staton

Industry Voices

More commentary

About Us - Staff
FEATURES
Top 5 Vaccine Companies by Revenue - 2012

Top 10 DTC Pharma Advertisers - H1 2013

20 Top-selling Vaccines -- H1 2012

Top 20 orphan drugs by 2018
Top 10 pharma companies by employees

10 promising therapeutic vaccines 2012

Major FDA vaccine approvals of 2012

Top 15 Drug Launch Superstars
LIBRARY
eBooks
Webinars
Videos
Surveys
Multimedia
View All
EVENTS
Jobs
Marketplace

Tag:

Neon Therapeutics

Latest Headlines

Latest Headlines

Focusing on neoantigens, Neon Therapeutics launches with a $55M Series A

October 1, 2015 | By Eric Sagonowsky

Fresh off of a $55 million Series A financing round, Neon Therapeutics jumped into the cancer vaccines space today with the aim of utilizing neoantigen biology to unlock a powerful immune response against the disease.

THE LIBRARY: WEBINAR

Enhancing the Customer Experience with Engaging Patient Services Applications

| January 12, 2016 | 1pm ET / 10am PT | Presented By: Salesforce

Patients increasingly have more control over their healthcare and information, and expect support services, access to their data, and anytime engagement. Join Harvey Guindi and Arun Bhaskar from Health Network Laboratories to hear how they transformed their patient relationships with an engaging suite of applications built on the Force.com platform. Reserve Your Spot Today!

MORE ITEMS

EVENTS

FierceBiotech Breakfast Big Data: 2025 at the J.P. Morgan Healthcare Conference - Register Today!January 12, 2016 — San Francisco, CA — Sponsored by: Astellas and Deloitte

MORE EVENTS

Press Releases

Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV Vaccine
Turing Pharmaceuticals AG Announces Appointment of Ron Tilles as Interim CEO
Luminex Corporation Receives FDA Clearance for NxTAG Respiratory Pathogen Panel
GSK's global HIV business ViiV Healthcare to acquire Bristol-Myers Squibb's R&D HIV assets
GSK's global HIV business ViiV Healthcare to acquire Bristol-Myers Squibb's R&D HIV assets
More Press Releases

Sponsored Links

A publication ofFierceMarkets

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom

FierceCable
FierceDeveloper
FierceWireless:Europe
FierceWirelessTech
FierceOnlineVideo
FierceTelecom
FierceWireless
FierceInstaller

Marketing & Retail

FierceCMO
FierceMobileMarketer
FierceRetail
FierceRetailIT
FierceMobileRetail

Healthcare

FierceEMR
FierceHealthcare
FierceHealthFinance
FierceHealthIT
FierceHealthPayer
FierceHealthPayerAntiFraud
FierceMobileHealthcare
FiercePracticeManagement
Hospital Impact

Government

FierceGovernment
FierceGovernmentIT
FierceHomelandSecurity
FierceMobileGovernment
FierceCities
FierceGovHealthIT

Life Sciences

FierceBiotechResearch
FierceBiotech
FierceBiotechIT
FierceCRO
FierceDrugDelivery
FierceMedicalDevices
FiercePharma
FiercePharmaAsia
FiercePharmaManufacturing
FiercePharmaMarketing
FierceVaccines
FierceAnimalHealth

Enterprise IT

FierceBigData
FierceCIO
FierceContentManagement
FierceDevOps
FierceEnterpriseCommunications
FierceITSecurity
FierceMobileIT

Energy

FierceEnergy
SmartGridNews
FierceWater

Finance

FierceCFO
FierceFinanceIT